Letters β blockers for heart failure Adverse effects and tolerability of β blockers BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3142 (Published 07 June 2016) Cite this as: BMJ 2016;353:i3142 Article Related content Metrics Responses Peer review Related articles Research Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis Published: 20 April 2016; BMJ 353 doi:10.1136/bmj.i1855 Letter Authors’ reply to Cunningham and Messerli and colleagues Published: 07 June 2016; BMJ 353 doi:10.1136/bmj.i3141 See more Patients with asthma or heart disease should avoid incense sticks and other airborne pollutants, says CMO BMJ June 03, 2025, 389 r1146; DOI: https://doi.org/10.1136/bmj.r1146 Why are UK cardiovascular deaths in under 65s rising again? BMJ May 19, 2025, 389 r1015; DOI: https://doi.org/10.1136/bmj.r1015 Prescribing parkrun: medicalising a walk in the park BMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670 GPs can prescribe tirzepatide to priority patient groups from June BMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665 Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reports BMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287 Cited by... Authors reply to Cunningham and Messerli and colleaguesFulltext PDF
